GLP-2 Receptor Agonist Analog (TRZ designation) is supplied as lyophilized powder in 60mg vials, providing maximum research capacity for comprehensive intestinal physiology investigation and extensive preclinical characterization. This premium dosage enables large-scale translational research initiatives.

Chemical Composition:

• Chemical Name: GLP-2 Receptor Agonist Analog
• Molecular Formula: C185H291N51O59S6 (representative structure)
• Molecular Weight: ~3,981 g/mol (approximate)
• Compound Class: GLP-2 receptor agonist; intestinotrophic hormone analog

The 60mg vial format facilitates complex, multi-institutional research programs evaluating GLP-2 agonist effects across spectrum of gastrointestinal diseases, investigation of long-term adaptation mechanisms following chronic GLP-2 receptor agonist treatment in healthy and diseased states, comprehensive assessment of potential therapeutic applications in diverse clinical contexts from mucosal healing to nutrient malabsorption rescue, and detailed mechanistic characterization of systemic metabolic and immunological consequences of intestinal functional restoration. Research encompasses investigation of GLP-2-mediated changes in intestinal epithelial cell tight junction organization and expression, evaluation of barrier function restoration mechanisms in inflammatory bowel disease context, assessment of mucosal-associated lymphoid tissue (MALT) maturation and functional competence, and characterization of long-term microbiome stability and diversity following GLP-2 agonist-induced dysbiosis correction.

Research Applications:

• Long-term intestinal adaptation assessment following chronic GLP-2 receptor activation
• Tight junction architecture and protein complex reorganization via electron microscopy
• MALT lymphocyte populations and immunoglobulin-producing cell assessment
• Microbiome stability and functional capacity assessment via metagenomics and metabolomics
• Systemic immune tolerance markers and anti-inflammatory T regulatory cell expansion

Storage and Handling:

• Maintain lyophilized powder at -20°C in sealed, light-protected vials
• Store in desiccated environment with desiccant packets included
• Reconstitute with sterile, endotoxin-free water for fresh solutions
• Reconstituted solutions remain stable at 4°C for up to 7 days

Product Specifications:

• Form: Lyophilized powder
• Quantity: 60mg per vial
• Purity: >95% by HPLC
• Appearance: White crystalline lyophilized powder

FOR RESEARCH USE ONLY. Not intended for human consumption or clinical use. All products are sold strictly for laboratory, educational, and scientific research purposes.